CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 112 enrolled
Drug / intervention
VenaCure EVLT 400 µm fiber Procedure Kitdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02215369
NCT02215369N/ACompleted
CompareCT.gov

Prospective Safety and Effectiveness Study: VenaCure Endovenous Laser Treatment (EVLT) 400 µm Fiber Procedure Kit for Treatment of Incompetent Perforator Veins

Angiodynamics, Inc.·interventional·Posted Aug 13, 2014·Updated May 19, 2020

In Brief

A clinical study evaluating VenaCure EVLT 400 µm fiber Procedure Kit for Chronic Venous Insufficiency. Completed, enrolled 112 participants across 7 sites.

Detailed Summary

The VenaCure EVLT 400 µm Fiber Kit is currently marketed for the treatment of varicose veins. AngioDynamics, Inc., the company that manufacturers the VenaCure device, is sponsoring this study to assess the safety and effectiveness of the VenaCure EndoVenous Laser Treatment (EVLT) 400 µm Fiber Kit for treatment of incompetent perforator veins (IPVs). The VenaCure EVLT 400 µm Fiber Kit has not been previously studied by AngioDynamics for the ablation of IPVs.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Venous Insufficiency
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedAug 13, 2014
Enrollment StartJan 1, 2015
Primary CompletionMar 1, 2018
Study CompletionJan 14, 2019
TodayJul 2, 2026
Enrollment to primary: 3.2 yearsPosted 11.9 years ago

Interventions

VenaCure EVLT 400 µm fiber Procedure Kitdevice

The study intervention will be conducted according to the DFU included with the VenaCure EVLT 400 µm fiber Procedure Kit.